|
April 14th at 10AM EST CLICK HERE for webcast link. |
The decline in cannabis stocks and especially GRAMF has been painful. During this downturn, the industry fundamentals have only gotten stronger, with NY and other states opening up to medical and recreational sales. The SAFE Act was re-introduced and will likely make its way through the House and the Senate in short order, where it has several sponsors.
GRAMF also trades at a discount to others in the space due to its concentration in the California market. To some degree, the California cannabis market is miss understood. Since going recreational, the California 1.0 "green rush" led to some bad actors and poor handling of the rollout that lead to investors losing a significant amount of money. In some respects the California market is underserved and is moving into a new phase of growth or California 2.0. As a "mature market" there are 706 dispensary licensees in the state, leading to one dispensary for every 38,000 residents. This is on par with other limited license states like AZ, MA, NV, MD, and FL.
So why the weakness in the industry? We will discuss these and other issues with Michael Auerbach. Michael is an entrepreneur, cannabis investor, business consultant, media producer, and private diplomat. He is the Founder of Subversive Capital, dedicated to investing in radical companies whose core missions subvert the status quo and require sophisticated government and regulatory strategies for success. Subversive Capital recently acquired The Parent Company, the Largest Vertically Integrated Omnichannel Cannabis Platform in California.
